Table 1.
Recipient | All | Death <1 yr (n = 17) | |
---|---|---|---|
Age, yr (mean ± SD) | 73.3 ± 2.5 | 74.0 ± 2.6 | |
Range, yr | 70.0–82.4 | 70.0–78.5 | |
Male, n (%) | 116 (67.8) | 12 (70.6) | |
BMI, kg/m2 (mean ± SD) | 25.5 ± 3.4 | 23.8 ± 1.9 | |
Primary renal disease, n (%) | |||
Diabetes | 28 (16.4) | 2 (11.8) | |
Vascular | 27 (15.8) | 7 (41.2) | |
Interstitial | 19 (11.1) | 2 (11.8) | |
Glomerular | 25 (14.6) | 1 (5.9) | |
Polycystic | 23 (13.5) | 2 (11.8) | |
Unknown | 34 (19.9) | 2 (11.8) | |
Mode of dialysis, n (%) | |||
Preemptive transplant | 24 (14) | 0 (0) | |
Hemodialysis | 123 (72.8) | 15 (88.2) | |
Peritoneal dialysis | 22 (13) | 2 (11.8) | |
Time on dialysis before transplant, yr (mean ± SD) | 2.7 ± 2.5 | 3.9 ± 2.8 | |
Waiting time, yr (mean ± SD) | 0.97 ± 0.97 | 1.2 ± 0.9 | |
HLA antibodies, n (%) | 38 (22.2) | 6 (35.3) | |
Comorbidities, n (%) | |||
Hypertension | 159 (95.2) | 16 (94.1) | |
Diabetes | 40 (23.9) | 3 (17.6) | |
Coronary artery disease | 35 (20.9) | 6 (35.3) | |
Cardiomyopathy | 72 (43.1) | 10 (58.8) | |
Peripheral vascular disease | 24 (14.1) | 3 (17.6) | |
Arrhythmia | 28 (16.8) | 5 (29.4) | |
Plasma albumin (g/L) | 39.7 ± 4.6 | 40 ± 0.5 | |
Donor | |||
Deceased donor, n (%) | 168 (98.2) | 17 (100) | |
Deceased from cardiovascular cause | 121 (72.9) | 15 (88.2) | |
Age, yr (mean ± SD) | 70.1 ± 10.5 | 70 ± 7.5 | |
Transplantation characteristics | |||
Cold ischemic time, h (mean ± SD) | 17.8 ± 5 | 17.3 ± 2.6 | |
Delayed graft function, n (%) | 48 (30.6) | 3 (17.6) | |
Initial hospitalization duration | 22.3 ± 22 | 31.1 ± 32 | |
Range, d | 3–173 | 4–140 |
BMI, body mass index; HLA, human leucocyte antigen; KT, kidney transplant.